Showing results (1971-1980 of 1,982) with videos related to

Sort By:
Pageof 199
Free Radical Research|October 22, 2019
Visualising reactive oxygen species in live mammals and revealing of ROS-related systemJingke Guo, Hang Xu, Shutao Liu, et al.
Blood Advances|February 15, 2024
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, et al.
Blood|January 12, 2024
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLLJennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, et al.
Blood|October 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRSR Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, et al.
The New England Journal of Medicine|December 4, 2018
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLLJennifer A Woyach, Amy S Ruppert, Nyla A Heerema, et al.
NPJ Vaccines|March 19, 2023
Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccinationZhao Yu-Ping, Li Jing, Huang Teng, et al.
Cancer Immunology Research|June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T CellsR Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Blood|April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLLWei Ding, Betsy R LaPlant, Timothy G Call, et al.
Genome Medicine|June 2, 2016
Development and clinical application of an integrative genomic approach to personalized cancer therapyAndrew V Uzilov, Wei Ding, Marc Y Fink, et al.
The Lancet. Digital Health|June 6, 2020
Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort studyBei Mao, Yang Liu, Yan-Hua Chai, et al.
Pageof 199